Western blot analysis showed inhibitory activity on the expression of related proteins in the protein kinase B/mammalian target of rapamycin (Akt/mTOR) signalling pathway by IOP, indicating that the antitumor effect of IOP against osteosarcoma is through hindering Akt/mTOR activation. The gene discussed is AKT1; the disease is osteosarcoma.